Considering the widespread concern of the methyltransferase ZC3H13, researchers have proposed the following views: ZC3H13 is expected to be a marker for evaluating the prognosis of patients with hepatocellular carcinoma [13]. This evidence concerns the gene ZC3H13 and hepatocellular carcinoma.